Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of a New Chewable Tablet of Mebendazole Versus the Swallowable, Standard Tablet of Mebendazole Against Hookworm Infections in Children: a Randomized Controlled Trial

NCT03995680 is registered in ClinicalTrials.gov with Swiss Tropical & Public Health Institute as lead sponsor.

NCT NCT03995680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03995680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of a New Chewable Tablet of Mebendazole Versus the Swallowable, Standard Tablet of Mebendazole Against Hookworm Infections in Children: a Randomized Controlled Trial
Lead sponsor
Swiss Tropical & Public Health Institute
Phase
Phase 2
Overall status
Completed
Start date
July 12, 2019
Completion date
October 9, 2019
Enrollment
397 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hookworm infections